<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0" />
  <title>HEARTMAP</title>
  <link href="https://cdn.jsdelivr.net/npm/tailwindcss@2.2.19/dist/tailwind.min.css" rel="stylesheet">
  <link rel="icon" type="image/x-icon" href="favicon.ico">
</head>
<body class="bg-gray-50 text-gray-900">
  <header class="bg-red-500 text-white p-6 text-center space-y-4">
    <div class="flex justify-center">
      <img src="heartmaplogo.png" alt="Heartmap Logo" width="100" height="100" />
    </div>
    <h1 class="text-3xl font-bold">
      HEARTMAP: Hybrid Engineered Arrhythmia-Resistant Regenerative Tissue with Machine learning-Augmented Placement
    </h1>
    <p class="text-lg">an AI-guided solution to support heart regeneration</p>
  </header>

  <main class="p-6 space-y-12">
    
    <!-- Section 1: Health Impact -->
    <section>
      <h2 class="text-2xl font-semibold mb-4">üß¨imagine this:</h2>
      <div class="flex flex-col md:flex-row items-center md:items-start gap-6">
        <img src="grandma.png" alt="Grandma" width="100" height="100" class="flex-shrink-0" />
        <div class="text-right md:text-left space-y-4">
          <p>you‚Äôve just survived a heart attack. you‚Äôre told to ‚Äúrest,‚Äù but your heart skips, stalls, and you‚Äôre scared. you‚Äôre 50, and already being fitted for a defibrillator. no one mentions recovery. just risk. meanwhile, the technology exists ‚Äî but not for you.</p>
          <p>1 in 4 cardiac patients experience a second major event within 5 years. cardiac patches exist, but they‚Äôre often one-size-fits-all ‚Äî failing to match the rhythm of your actual heart.</p>
        </div>
      </div>
    </section>

    <!-- Section 2: The Innovation -->
    <section>
      <h2 class="text-2xl font-semibold mb-4">üß¨the problem: <span class="text-red-600 font-bold">engineered patches fail to integrate electrically</span></h2>
      <ul class="list-disc ml-6 space-y-2">
        <li>
          <span class="text-red-600 font-bold">Placement is imprecise</span>, based on guesswork. Inaccurate placement of electrodes can significantly affect the morphology of ECG waveforms, potentially leading to misinterpretation of cardiac rhythms. This underscores the importance of <span class="font-bold text-red-600">precise placement</span> to ensure accurate diagnosis and effective treatment.
        </li>
        <li>
          <span class="text-red-600 font-bold">Electrical mismatch leads to arrhythmias</span>. Studies have shown that spatial profiles of electrical mismatch can determine vulnerability to reentrant arrhythmias. This highlights the critical need for <span class="text-red-600 font-bold">electrical compatibility</span> between the patch and the host tissue to prevent adverse outcomes.
        </li>
        <li>
          <span class="text-red-600 font-bold">Post-MI hearts vary widely ‚Äî but patches don‚Äôt</span>. After a myocardial infarction (MI), the heart undergoes complex remodeling, resulting in heterogeneous tissue characteristics that are not adequately addressed by standardized patches (<em>Proceedings of the National Academy of Sciences</em>).
        </li>
        <li>
          <span class="text-red-600 font-bold">iPSC-derived cardiomyocytes (iPSC-CMs)</span> often exhibit immature electrical properties, leading to poor integration with native cardiac tissue.
        </li>
      </ul>
    </section>
    
    <section>
    <h2 class="text-2xl font-semibold mb-4">üß¨wait, what are hiPSC-CMs?</h2>
      <p>human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) offer a promising cell source for cardiac regeneration due to their ability to differentiate into functional cardiomyocytes. Preclinical studies have demonstrated improved cardiac function following transplantation of hiPSC-CM patches in animal models.</p>
    </section>

    <!-- Section 3: 3D Model -->
    <section>
      <h2 class="text-2xl font-semibold mb-4">üß¨proposed solution</h2>
      <div class="aspect-w-16 aspect-h-9"></div>
      <p>the HEARTMAP team proposes the development of a novel cardiac patch scaffold embedded with conductive polymers (e.g., polypyrrole or reduced graphene oxide) seeded with iPSC-CMs. To enhance therapeutic precision, we will integrate machine learning (ML) models trained on patient-specific electrogram and imaging data to guide patch placement and predict arrhythmic zones.</p>         
      <p class="aspect-w-16 aspect-h-9">regenerating heart tissue starts long before a patch ever reaches the heart. It begins at the cellular level ‚Äî where a single stem cell is guided to become a beating cardiomyocyte.</p>

 <h3 class="text-2xl font-semibold mb-6">üß¨ the journey:</h3>

<div class="flex justify-center mb-6">
  <img src="stemcells.png" alt="Stemcells Graphic" class="w-3/4 max-w-xl rounded" />
</div>

<ul class="list-disc list-inside ml-6 space-y-2 mb-4">
  <li><strong>Activin A</strong> triggers mesoderm formation ‚Äî the germ layer that gives rise to the heart.</li>
  <li><strong>BMP4</strong> nudges cells toward cardiac progenitor identity.</li>
  <li><strong>FGF2</strong> supports proliferation and survival of early cardiac cells.</li>
</ul>

<ul class="list-disc list-inside ml-6 space-y-2">
  <li><strong>Matrix stiffness</strong> must mimic natural heart tissue.</li>
  <li><strong>Electrical cues</strong> guide alignment and contractility of cardiomyocytes.</li>
</ul>

  <p class="mb-8 italic text-gray-700">these factors work together to ensure the resulting cells are ready to sync with the patient‚Äôs heart.</p>

 <div class="flex flex-col md:flex-row items-start gap-6 mb-6">
  <img src="patch_making.png" alt="Patchmaking Graphic" width="300" height="100" class="md:w-1/3" />

  <div class="md:w-2/3">
    <h3 class="text-2xl font-bold mb-4">üß¨ biocompatibility: beyond just ‚Äúsafe‚Äù</h3>
    <ul class="list-disc list-inside ml-6 space-y-2">
      <li><strong>Non-cytotoxicity</strong>: materials must not harm cells or trigger rejection.</li>
      <li><strong>Mechanical compliance</strong>: patches must ‚Äúbeat‚Äù with the heart.</li>
      <li><strong>Cellular integration</strong>: scaffolds must support gap junctions (e.g., <em>connexin 43</em>).</li>
    </ul>
  </div>
</div>


  <p class="mb-6">materials like <strong>rGO</strong> and <strong>PPy</strong> are promising ‚Äî they offer conductivity and support alignment of cardiomyocytes.</p>
  <p class="mb-8 text-gray-700 italic">Referenced: Guo et al., 2023, <em>Bioactive Materials</em>.</p>
</section>

    <!-- Section 4: The Patch -->
<section class="my-8">
  <h2 class="text-2xl font-semibold mb-4">üß¨ the patch</h2>

  <div class="flex flex-col md:flex-row items-start gap-6">
    <img src="patch_demo.png" alt="Cardiac Patch" width="300" height="300" class="md:w-1/3 rounded" />

    <ul class="list-disc space-y-2 md:w-2/3">
      <li><strong>Scaffold</strong>: Biodegradable hydrogel scaffold infused with conductive polymer (PPy or rGO)</li>
      <li><strong>Cells</strong>: Human iPSC-CMs validated for purity, conduction, and contractile protein expression</li>
      <li><strong>Conductivity Enhancement</strong>: Scaffold modified to match anisotropic conduction of native myocardium</li>
    </ul>
  </div>
</section>


    <!-- Section 5: ML Model -->
    <section>
      <h2 class="text-2xl font-semibold mb-4">üß¨ machine learning model</h2>
      <div class="aspect-w-16 aspect-h-9"></div>
      <p>for many bioengineered solutions, scalability and biocompatibility remain barriers. however, an ML approach could be a promising change.</p>
      <ul class="list-disc ml-6 space-y-2">
        <li>Input: Electrogram data, cardiac MRI, LGE-MRI scar segmentation</li>
        <li>Output: Predictive placement heatmap, arrhythmic vulnerability index</li>
        <li>Algorithm: 3D U-Net with attention layers, trained on &gt;100 anonymized ECG/imaging datasets</li>
      </ul>
    </section>

  <h2 class="text-text-2xl font-semibold mb-4">üß¨ ethics in regenerative medicine</h2>
  <p class=" ml-6 space-y-2">Regenerative therapies offer hope ‚Äî but not without risk. We believe that advancing medicine must never come at the cost of ethics.</p>

  <h3 class="text-xl font-semibold mt-6 mb-2">1. stem cell risks and sourcing</h3>
  <ul class="list-disc list-inside  ml-6 space-y-2">
    <li><strong>tumorigenicity</strong>: undifferentiated iPSCs can cause uncontrolled growth if not fully cleared.</li>
    <li><strong>ethical sourcing</strong>: Were iPSCs autologous or allogeneic? Was informed consent obtained?</li>
  </ul>

  <p class="mb-6 text-gray-700 italic">Miyagawa et al., 2023 emphasized safety monitoring in iPSC-CM patch clinical trials.</p>

  <h3 class="text-xl font-semibold mt-6 mb-2">2. digital risk</h3>
  <ul class="list-disc list-inside mb-6 space-y-2">
    <li>AI-analyzed ECGs and imaging could raise <strong>data privacy</strong> concerns.</li>
    <li>Autonomous surgical guidance tools must be continuously validated to avoid harm.</li>
  </ul>

  <h3 class="text-2xl font-bold mb-4">üß¨ clinical transparency and long-term trust</h3>
  <p class="mb-4">all first-in-human trials using regenerative heart patches must follow <strong>Health Canada‚Äôs Special Access Program</strong>. We commit to:</p>
  <ul class="list-disc list-inside mb-6 space-y-2">
    <li><strong>clear informed consent</strong> for patients and families.</li>
    <li><strong>thoughtful patient selection</strong> based on medical criteria.</li>
    <li><strong>long-term monitoring</strong> to detect adverse effects and ensure success.</li>
  </ul>

    <!-- Section 6: Clinical Trial -->
    <section>
      <h2 class="text-2xl font-semibold mb-4">üß¨ how do we build it?</h2>
      <img src="yay.png" alt="Cardiac Patch Process" width="624" height="1536" class="mx-auto mb-6" />

      <h3 class="text-xl font-semibold text-red-600 mb-2">Proposed Clinical Trial Structure: Trial #1</h3>
      <ul class="list-disc pl-6 space-y-2">
        <li><span class="font-bold text-red-600">Animal Model:</span> Yorkshire pigs, MI induced via LAD ligation (n=10 with patch, n=10 control)</li>
        <li><span class="font-bold text-red-600">Implantation Site Determination:</span> AI-based predictive modeling using real-time electrogram mapping</li>
        <li><span class="font-bold text-red-600">Procedure:</span> Patch applied epicardially under general anesthesia</li>
        <li><span class="font-bold text-red-600">Endpoints:</span>
          <ul class="list-disc pl-6">
            <li>Electromechanical coupling (optical mapping + ECG)</li>
            <li>Fibrosis volume (histology)</li>
            <li>Arrhythmia incidence (telemetry)</li>
            <li>Histological evidence of iPSC-CM retention and alignment</li>
          </ul>
        </li>
        <li><span class="font-bold text-red-600">Reference Study:</span> Wong RC et al., UHN (2020), <em>‚ÄúTransplantation of iPSC-derived cardiac tissue in swine post-MI improves functional recovery‚Äù</em> ‚Äì Canadian Journal of Cardiology</li>
      </ul>

      <h3 class="text-xl font-semibold text-red-600 mt-8 mb-2">Proposed Clinical Trial Structure: Trial #2</h3>
      <ul class="list-disc pl-6 space-y-2">
        <li><span class="font-bold text-red-600">Eligibility Criteria:</span> Adult patients (18‚Äì70) with ischemic cardiomyopathy, NYHA Class II‚ÄìIII symptoms, and documented infarction within 1 year</li>
        <li><span class="font-bold text-red-600">Surgical Procedure:</span>
          <ul class="list-disc pl-6">
            <li>Patch generated in GMP facility from autologous or allogeneic iPSCs</li>
            <li>Conductive scaffold fabricated and seeded ex vivo, validated for sterility</li>
            <li>AI-generated placement map used to guide epicardial placement</li>
          </ul>
        </li>
        <li><span class="font-bold text-red-600">Safety Monitoring:</span>
          <ul class="list-disc pl-6">
            <li>ECG and Holter monitoring for 30 days post-implant</li>
            <li>Echocardiogram at baseline, 30, 90, and 180 days</li>
            <li>Cardiac MRI at 90 days to assess remodeling and patch integration</li>
          </ul>
        </li>
      </ul>
    </section>

    <!-- Section 7: Scaling -->
    <section>
      <h2 class="text-2xl font-semibold mb-4">üß¨ how do we scale?</h2>
      <p>proposed partners: Ted Rogers Centre for Heart Research (UHN + SickKids + U of T) ‚Äì Comprehensive cardiology and iPSC expertise</p>
    </section>

    <!-- Section 8: Behind the Scenes -->
    <section>
      <h2 class="text-2xl font-semibold mb-4">üß¨ behind the scenes:</h2>
      <p>This project combines regenerative engineering, AI, and material science. Illustrations were done through the use of ChatGPT, with supporting research from recent publications in cardiac bioengineering. Website + prototype by Elena Osipyan :) </p>
    </section>

    <!-- Section 9: References -->
    <section>
      <h2 class="text-2xl font-semibold mb-4">üß¨ references:</h2>
      <ul class="list-disc ml-6">
  <li>
    <b>Zhang, Donghui</b>, et al. <i>‚Äú3D Bioprinting of Cell-Laden Cardiac Patch for Heart Regeneration.‚Äù</i> <b><i>NPJ Regenerative Medicine</i></b>, vol. 6, 2021. 
    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318604/" class="text-blue-600">Link</a>
  </li>
  <li>
    <b>Ntagiantas, Evagelos</b>, and <b>Marco Pignatelli</b>. <i>‚ÄúEstimating Cardiac Tissue Conductivity from Electrograms with Fully Convolutional Networks.‚Äù</i> <b><i>Semantic Scholar</i></b>, 2022. 
    <a href="https://www.semanticscholar.org/paper/74c70d4c4dadd3e5fea6cbea75982fe19773b7a5" class="text-blue-600">Link</a>
  </li>
  <li>
    <b>Shin, Seung Rim</b>, et al. <i>‚ÄúElectroconductive Biomaterials for Cardiac Tissue Engineering.‚Äù</i> <b><i>Frontiers in Bioengineering and Biotechnology</i></b>, vol. 10, 2022. 
    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935982/" class="text-blue-600">Link</a>
  </li>
  <li>
    <b>Khan, Tareq</b>, et al. <i>‚ÄúAdvances in Conductive Biomaterials for Cardiac Tissue Engineering: Design, Fabrication, and Functional Integration.‚Äù</i> <b><i>Polymers</i></b>, vol. 17, no. 5, 2025. 
    <a href="https://www.mdpi.com/2073-4360/17/5/620" class="text-blue-600">Link</a>
  </li>
  <li>
    <b>Liu, Yuxuan</b>, et al. <i>‚ÄúLarge Cardiac Muscle Patches Engineered From Human Induced-Pluripotent Stem Cell‚ÄìDerived Cardiac Cells Improve Recovery from Myocardial Infarction in Swine.‚Äù</i> <b><i>Circulation</i></b>, vol. 137, no. 16, 2018. 
    <a href="https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.117.030785" class="text-blue-600">Link</a>
  </li>
  <li>
    <b>Miyagawa, Shigeru</b>, et al. <i>‚ÄúSafety Confirmation of Induced Pluripotent Stem Cell‚ÄìDerived Cardiomyocyte Patches for Clinical Application.‚Äù</i> <b><i>NPJ Regenerative Medicine</i></b>, vol. 8, no. 1, 2023. 
    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10540447/" class="text-blue-600">Link</a>
  </li>
  <li>
    <b>Menasch√©, Philippe</b>. <i>‚ÄúCell Therapy Trials for Heart Regeneration‚ÄîLessons Learned and Future Directions.‚Äù</i> <b><i>Nature Reviews Cardiology</i></b>, vol. 15, 2018. 
    <a href="https://doi.org/10.1038/s41569-018-0052-7" class="text-blue-600">Link</a>
  </li>
  <li>
    <b>Guo, Rui</b>, et al. <i>‚ÄúEngineering a Conduction-Consistent Cardiac Patch with rGO/PLCL Electrospun Nanofibrous Membrane and Human iPSC-Derived Cardiomyocytes.‚Äù</i> <b><i>Bioactive Materials</i></b>, vol. 20, 2023. 
    <a href="https://www.sciencedirect.com/science/article/pii/S2452199X23000512" class="text-blue-600">Link</a>
  </li>
  <li>
    <b>Ting, Daniel S.W.</b>, et al. <i>‚ÄúArtificial Intelligence and Deep Learning in Cardiovascular Imaging.‚Äù</i> <b><i>Nature Reviews Cardiology</i></b>, vol. 18, 2021. 
    <a href="https://www.nature.com/articles/s41569-020-00427-2" class="text-blue-600">Link</a>
  </li>
</ul>

    </section>

  </main>

  <footer class="bg-gray-100 text-center p-4 mt-12">
    <p>Made with ‚ù§Ô∏è for the INVENIRE Challenge. | GitHub: 
      <a href="https://osipyaan.github.io/heartmap/" class="text-blue-600">osipyaan/heartmap</a>
    </p>
  </footer>
</body>
</html>
